Your browser doesn't support javascript.
loading
Patch test in Chinese in Shanghai with cosmetic allergy to cosmetic series and products.
Qin, Ou; Cheng, Ying; Hu, Weiyi; Zhou, Hong; Tan, Yimei; Guo, Shuting; Jin, Xin; Tao, Lin; Du, Lei; Wang, Jieheng; Wang, Xuemin; Zou, Ying; Maibach, Howard.
Afiliação
  • Qin O; Skin and Cosmetic Research Department, Shanghai Skin Disease Hospital, Shanghai, China.
  • Cheng Y; Skin and Cosmetic Research Department, Shanghai Skin Disease Hospital, Shanghai, China.
  • Hu W; Skin and Cosmetic Research Department, Shanghai Skin Disease Hospital, Shanghai, China.
  • Zhou H; Skin and Cosmetic Research Department, Shanghai Skin Disease Hospital, Shanghai, China.
  • Tan Y; Skin and Cosmetic Research Department, Shanghai Skin Disease Hospital, Shanghai, China.
  • Guo S; Shanghai Food and Drug Administration, Shanghai, China.
  • Jin X; Shanghai Food and Drug Administration, Shanghai, China.
  • Tao L; Shanghai Center for Adverse Drug and Medical Device Reaction Monitoring, Shanghai, China.
  • Du L; Shanghai Center for Adverse Drug and Medical Device Reaction Monitoring, Shanghai, China.
  • Wang J; Shanghai Food and Drug Administration, Shanghai, China.
  • Wang X; Skin and Cosmetic Research Department, Shanghai Skin Disease Hospital, Shanghai, China.
  • Zou Y; Skin and Cosmetic Research Department, Shanghai Skin Disease Hospital, Shanghai, China.
  • Maibach H; Department of Dermatology, School of Medicine, University of California San Francisco, San Francisco, CA, USA.
J Cosmet Dermatol ; 19(8): 2086-2092, 2020 Aug.
Article em En | MEDLINE | ID: mdl-31820565
ABSTRACT

BACKGROUND:

There are increasing cosmetic adverse reactions in China, mostly cosmetic contact dermatitis, with the development of its cosmetics industry.

AIMS:

To identify the allergens and cosmetics products responsible for cosmetic allergic contact dermatitis (CACD) in Shanghai.

METHODS:

Five hundred and sixty patients, including 342 suspected CACD patients from dermatological clinic and 218 cosmetics consumers with an allergic history, were patch tested with a cosmetic series (C-1000 series). And 154 patients patched with possible culprit cosmetics.

RESULTS:

Two hundred and forty-six subjects showed positive reaction to C-1000 series. Clinic patients had much higher positive rate than that of cosmetics consumers. Leading allergens were methylisothiazolinone (MI), methylisothiazolinone + methylchloro-isothiazolinone (MCI/MI), thimerosal, and the positive rates were significantly higher in patients than in cosmetic consumers (P < .001 for all). MCI/MI elicited positive patch test reactions in 73.5% of MI-positive patients. Of those patched with cosmetic products, 19 patients had 31 positive reactions, including 22 skin care products and 5 color decorating.

CONCLUSIONS:

Preservatives, especially MI, MCI/MI, and thimerosal, were the most common cosmetic allergens, and skin care products occupied the most allergic reaction of CACD. Patch testing is highly recommended for suspected CACD patients. Future comparative investigation with large sample size should benefit cosmetovigilance surveillance.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dermatite Alérgica de Contato / Cosméticos Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies Limite: Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dermatite Alérgica de Contato / Cosméticos Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies Limite: Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2020 Tipo de documento: Article